Sami-Sabinsa’s Pterocarpus marsupium Reforestation Program Named Industry Initiative of The Year Award Finalist

Sami-Sabinsa Group

"The vision of a research scientist and a passionate entrepreneur takes on social and commercial expressions." This, in short, explains the genesis and growth of Sami-Sabinsa Group.

Sami-Sabinsa Group is a research-focused multinational health science company that was founded in 1991 by the late Dr. Muhammed Majeed, an internationally renowned scientist and entrepreneur in the field of evidence-based medicine. The company is a leading manufacturer of nutraceuticals and cosmeceutical ingredients, standardized herbal extracts, enzymes, probiotics, nutricosmetics, nutritional fine chemicals, and specialty chemicals.
Read More...

The Sami-Sabinsa Group’s ambitious 10-year reforestation program of Pterocarpus Marsupium trees in India has been chosen as one of two finalists in the NutraIngredients-USA Editors Award for Industry Initiative of the Year. The winner will be announced at an event in Chicago on July 16, 2018.

This reforestation program is the first of its kind in the herbal industry: proactively addressing future supply shortfall of a medicinal tree. Anticipating future demand as research confirms traditional Ayurvedic use for diabetes, Sami-Sabinsa learned that the Indian Kino tree population is threatened. Sami-Sabinsa developed and funded a collaborative program to plant 166,600 trees on 250 forest acres over ten years, the first conservation program for this high value threatened tree species in India. Sami-Sabinsa is conceived and funded the initiative, with cultivation managed by the reforestation organization Madhya Pradesh Rajya Van Vikas Nigam Limited on land provided by the forest department of the State of Madhya Pradesh.

Based on International Union for Conservation of Nature criteria, India’s Foundation for Revitalisation of Local Health Traditions evaluated the Indian Kino tree populations in various states in India and put the species in categories ranging from ‘Critically endangered’ to ‘Vulnerable’ depending upon region.

“We are honored that our reforestation program has been recognized as significant by the respected industry publication NutraIngredients-USA,” said Shaheen Majeed, Sabinsa’s worldwide president. “We hope that this innovative program will serve as a model for the industry to take a proactive, longer-term view of the botanical ingredients supply chain.”

Sabinsa’s proprietary ingredient extracts obtained from Pterocarpus Marsupium, and based upon licensed patents, are sold under the brand names, Silbinol^® and pTeroSol^®.

What We Do

Sami-Sabinsa Group Limited (formerly Sami Labs Limited), a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics, and enzymes.

The company’s corporate R&D encompasses independent research divisions, including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulation R&D. These divisions collaborate in a synergistic work model to produce products that adhere to international standards.

With the collective wisdom of over 120 research scientists, Sami-Sabinsa Group has developed standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe.